After adjusting by group and sensitivity analysis, they observed higher IL-6 levels (SMD: 0.30, 95%CI: 0.12–0.49) in patients with post-COVID-19 condition when compared with those without [29]. The gene discussed is IL6; the disease is COVID-19.